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Zika Virus 
Infection, 
Cambodia, 2010
To the Editor: Zika virus (ZIKV), 
a member of the family Flaviviridae, 
genus Flavivirus, was fi rst isolated 
from the blood of a sentinel rhesus 
monkey from the Zika Forest of Uganda 
in 1948 (1). Since that time, serologic 
studies and virus isolations have 
demonstrated that the virus has a wide 
geographic distribution, including 
eastern and western Africa; the Indian 
subcontinent; Southeast Asia; and 
most recently, Micronesia (2–5). The 
virus is transmitted primarily through 
the bite of infected mosquitoes and 
most likely is maintained in a zoonotic 
cycle involving nonhuman primates 
(1), although recent evidence suggests 
the possibility of occasional sexual 
transmission in humans (4). Few case 
reports have described the clinical 
characteristics of ZIKV infection 
in humans. Most reports describe 
a self-limiting febrile illness that 
could easily be mistaken for another 
arboviral infection, such as dengue 
or chikungunya fever. We report a 
confi rmed case of ZIKV infection in 
Cambodia.
Since 2006, the US Naval Medical 
Research Unit No. 2 (NAMRU-2) has 
conducted surveillance for acute fever 
to determine causes of the infection 
among patients who seek health care 
at local clinics in Cambodia. Patients 
were enrolled by the health clinic 
physician after they gave informed 
consent in accordance with an 
institutional review board protocol 
approved by NAMRU-2 and the 
National Ethics Committee for Human 
Research of Cambodia. At enrollment, 
the physician administered a 
questionnaire and collected specimens 
(blood and throat swabs). All items 
were transported to the NAMRU-2 
laboratory in Phnom Penh, where 
testing was conducted for a variety 
of viral, bacterial, and parasitic 
pathogens. In August 2010, a blood 
specimen was collected from a 3-year-
old boy at a health clinic in Kampong 
Speu Province, Cambodia. The child’s 
reported clinical symptoms included 
4 days of fever and sore throat and 
cough and a headache for 3 days. A 
maculopapular rash was not observed, 
and the boy was not hospitalized. The 
clinic staff conducted a follow-up 
interview and reported that the patient 
recovered fully.
ZIKV infection was confi rmed in 
this patient by using PCR, sequencing, 
and serology and through virus 
isolation. ELISA for chikungunya and 
dengue virus IgM and IgG antibodies 
on acute- and convalescent-phase 
serum was negative. A universal 
fl avivirus real-time PCR screen that 
targets the nonstructural (NS) 5 gene 
(6) determined that the patient’s 
serum was positive for fl avivirus 
RNA, but subsequent species-specifi c 
PCR ruled out 2 other fl aviviruses 
that are highly endemic to the region 
(dengue and Japanese encephalitis 
viruses) (7–9). This result was the 
fi rst nondengue, non–Japanese 
encephalitis virus fl avivirus detected 
after samples from ≈10,000 enrolled 
patients were tested. Nucleic acid 
sequencing of the amplicon isolated 
by gel purifi cation produced a 100-
bp fragment with 100% sequence 
identity to ZIKV (nucleotide position 
8,969 of the NS5 gene of the isolate 
GenBank accession no. EU545988). 
ZIKV infection subsequently 
was serologically confi rmed by 
hemagglutination-inhibition tests on 
paired serum samples. The patient’s 
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acute-phase sample was negative, 
but a convalescent-phase sample 
gave a positive reaction with ZIKV 
antigen to a serum dilution of 1:320 
and was negative to antigens for the 
4 dengue serotypes and yellow fever 
and West Nile viruses. These results 
demonstrate that the patient had a 
clear monotypic fl avivirus immune 
response with seroconversion against 
ZIKV, indicating a recent primary 
infection.
The most common signs and 
symptoms reported in confi rmed 
ZIKV infections are fever, headache, 
malaise, maculopapular rash, fatigue 
or myalgia, and arthritis and arthralgia 
(Table). In addition to fever and 
headache, the patient in this study had 
a sore throat and cough. Because of the 
patient’s age, additional information 
about symptoms was diffi cult to obtain.
The clinical characteristics 
exhibited by this case-patient are 
similar to those of shown in a small 
cluster of ZIKV infections described 
in Indonesia during 1977–1978 in 
which maculopapular rash was not 
observed (5). Maculopapular rash was 
reported as a common sign in case-
patients from the recent Yap Island 
outbreak (3), as well as in case reports 
from Uganda (2), Senegal, and the 
United States (4), A case report of 
laboratory-acquired ZIKV infection 
also noted the lack of maculopapular 
rash (10).
The clinical features of ZIKV 
infection are similar to those of 
dengue virus and chikungunya virus 
infections, and both arboviruses 
are found in Southeast Asia. In this 
region, laboratory-based confi rmation 
is essential. The extent of ZIKV 
infections in Cambodia is unknown; 
further studies are needed to clarify 
the prevalence and geographic 
distribution of ZIKV infection in the 
country.
Acknowledgments
We thank the enrolling health center 
staff at Kampong Speu Province and the 
NAMRU-2 staff who contributed to the 
execution of this study and the follow-up 
investigation. 
This study was funded by the US 
Department of Defense Global Emerging 
Infections Surveillance and Response 
System, a division of the Armed Forces 
Health Surveillance Center.
Vireak Heang, 
Chadwick Y. Yasuda, 
Ly Sovann, Andrew D. Haddow, 
Amelia P Travassos da Rosa, 
Robert B. Tesh, 
and Matthew R. Kasper1
Author affi liations: US Naval Medical 
Research Unit No. 2, Phnom Penh, 
Cambodia (V. Heang, C.Y. Yasuda); Ministry 
of Health, Phnom Penh (L. Sovann); 
University of Texas Medical Branch, 
Galveston, Texas, USA (A.D. Haddow, 
A.P. Travassos da Rosa, R.B. Tesh); and 
US Naval Medical Research Unit No. 2, 
Jakarta, Indonesia (M.R. Kasper)
DOI: http://dx.doi.org/10.3201/eid1802.111224
References
  1.  Dick GW, Kitchen SF, Haddow AJ. 
Zika virus. I. Isolations and serologi-
350 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 18, No. 2, February 2012
Table. Reported or observed clinical signs and symptoms in persons with Zika virus infection, 1962–2010 
Sign or symptom 
Country, year of infection origin,* no. (%) patients
Uganda,
1962, n = 1
Laboratory acquired, 
1973, n = 1
Indonesia,
1977–1978, n = 7
Micronesia,
2007, n = 28
Senegal/United
States, 2009, n = 3
Cambodia,
2010, n = 1
Fever 1 (100) 1 (100) 7 (100) 20 (65)  1 (100)
Headache 1 (100)   14 (45) 3 (100) 1 (100)
Malaise 1 (100)  5 (71)  3 (100)
Maculopapular rash 1 (100)   28 (100) 3 (100)
Fatigue or myalgia 1 (100) 1 (100) 1 (14) 14 (45) 1 (33)
Arthritis and arthralgia   1 (14) 20 (65) 3 (100)
Chills  1 (100) 2 (29)  2 (67)
Dizziness   5 (71)    
Joint swelling or edema    6 (19) 2 (67)
Stomachache   6 (86)    
Retro-orbital pain  1 (100)  12 (39)
Conjunctivitis   1 (14) 17 (55) 1 (33)
Anorexia   4 (57)    
Photophobia     1 (33)
Vomiting   1 (14) 3 (10)
Diarrhea   3 (43)    
Constipation   3 (43)    
Sore throat      1 (100)
Cough      1 (100)
Aphthous ulcer     2 (67)
Hypotension   2 (29)    
Hematuria   1 (14)    
Prostatitis     1 (33)
Hematospermia     1 (33)
Sweating  1 (100)     
Lightheadedness     1 (33)
*References: Uganda (2), laboratory-acquired (10), Indonesia (5), Micronesia (9), Senegal/United States (4). Blank cells indicate no reported information. 
1Current affi liation: US Naval Medical 
Research Unit No. 6, Lima, Peru.
LETTERS
cal specifi city. Trans R Soc Trop Med 
Hyg. 1952;46:509–20. http://dx.doi.org/
10.1016/0035-9203(52)90042-4
  2.  Simpson DI. Zika virus infection in man. 
Trans R Soc Trop Med Hyg. 1964;58:335–8. 
http://dx.doi.org/10.1016/0035-9203(64)
90201-9
  3.  Duffy MR, Chen TH, Hancock WT, 
Powers AM, Kool JL, Lanciotti RS, et 
al. Zika virus outbreak on Yap Island, 
Federated States of Micronesia. N Engl 
J Med. 2009;360:2536–43. http://dx.doi.
org/10.1056/NEJMoa0805715
  4.  Foy BD, Kobylinski KC, Chilson Foy JL, 
Blitvich BJ, Travassos da Rosa A, Had-
dow AD, et al. Probable non–vector-borne 
transmission of Zika virus, Colorado, 
USA. Emerg Infect Dis. 2011;17:880–2.
  5.  Olson JG, Ksiazek TG. Suhandiman, Tri-
wibowo. Zika virus, a cause of fever in 
Central Java, Indonesia. Trans R Soc Trop 
Med Hyg. 1981;75:389–93. http://dx.doi.
org/10.1016/0035-9203(81)90100-0
  6.  Moureau G, Temmam S, Gonzalez JP, 
Charrel RN, Grard G, de Lamballerie 
X. A real-time RT-PCR method for the 
universal detection and identifi cation of 
fl aviviruses. Vector Borne Zoonotic Dis. 
2007;7:467–77. http://dx.doi.org/10.1089/
vbz.2007.0206
  7.  Santhosh SR, Parida MM, Dash PK, Pa-
teriya A, Pattnaik B, Pradhan HK, et al. 
Development and evaluation of SYBR 
Green I-based one-step real-time RT-
PCR assay for detection and quantitation 
of Japanese encephalitis virus. J Virol 
Methods. 2007;143:73–80. http://dx.doi.
org/10.1016/j.jviromet.2007.02.011
  8.  Reynes JM, Ong S, Mey C, Ngan C, Hoyer 
S, Sall AA. Improved molecular detection 
of dengue virus serotype 1 variants. J Clin 
Microbiol. 2003;41:3864–7. http://dx.doi.
org/10.1128/JCM.41.8.3864-3867.2003
  9.  Lanciotti RS, Calisher CH, Gubler DJ, 
Chang GJ, Vorndam AV. Rapid detection 
and typing of dengue viruses from clinical 
samples by using reverse transcriptase-
polymerase chain reaction. J Clin Micro-
biol. 1992;30:545–51.
10.  Filipe AR, Martins CM, Rocha H. Labora-
tory infection with Zika virus after vacci-
nation against yellow fever. Arch Gesamte 
Virusforsch. 1973;43:315–9. http://dx.doi.
org/10.1007/BF01556147
Address for correspondence: Matthew R. 
Kasper, US Embassy Lima, NAMRU-6, Unit 
3230, Box 46, DPO AA 34031, USA; email: 
matthew.kasper@med.navy.mil
Recombination 
of Human 
Coxsackievirus B5 
in Hand, Foot, 
and Mouth Disease 
Patients, China
To the Editor: Hand, foot, and 
mouth disease (HFMD) is an acute 
viral infectious disease in infants 
and young children. However, since 
2008, HFMD has emerged as a major 
public health problem in the People’s 
Republic of China, resulting in 
millions of infections with hundreds 
of deaths (1). Human enteroviruses 
(HEVs), including HEV71, 
echoviruses, and coxsackie viruses A 
and B (CAV and CBV), are the major 
pathogens of HFMD (2). In mainland 
China, HEV71 and CAV16 have been 
recognized as the dominant causative 
agents for HFMD.
During a recent HFMD outbreak 
in Changchun during 2010, three of 
16 throat swab samples tested positive 
for HEV but negative for HEV71 
and CAV16 by reverse transcription 
PCR. All 3 samples were then placed 
into human rhabdomyosarcoma 
cells, and typical cytopathic effects 
were observed 3–4 days later. All the 
isolates were fi nally characterized 
as CBV5 by using serologic and 
molecular technology and designated 
as CBV5/CC10/10, CBV5/CC10/16, 
and CBV5/CC10/17, respectively. The 
complete genome of these Changchun 
isolates was determined as described 
(3) and submitted to GenBank 
(accession nos. JN580070, JN695050, 
and JN695051, respectively. The 
genome RNA of CBV5/CC10/10 
is 7,402 bp long, and the 5′- and 
3′-untranslated regions are 743 and 
101 bp, respectively. The coding 
regions of these Changchun isolates 
are highly homologous, with amino 
acid identity of 100% and only a 3-nt 
difference exists among them. The 
complete genome of 4 CBV5 strains 
were indexed previously in GenBank, 
and the nucleotide sequence identities 
of the newly isolated CBV5/CC10/10 
with the other 4 CBV5 strains were 
among 80.6%–88.1%. Results of 
homology and phylogenetic analyses 
based on the complete viral protein 
1 sequence (849 bp) showed that the 
nucleotide identity of viral protein 
1 among 17 different CBV5 strains 
was 78.9%–95.6% and the amino 
acid identity was 92.9%–98.9%. The 
neighbor-joining tree indicated that 
the new isolated CBV5 Changchun 
strains were most closely related to 
the strains isolated from mainland 
China and that they divided into a 
distinct lineage from other CBV5 
strains outside China (Figure). CBV5 
infections were reported in mainland 
China during 2002–2010 in Zhejiang, 
Shandong, and Henan Provinces 
(4). These Changchun isolates were 
highly homologous with the recent 
Henan isolate, COXB5/Henan/2010, 
with a nucleotide identity of 88.1%. 
These results indicated that CBV5 
might have been circulating in China 
for nany years and represented an 
independent evolution tendency.
Homology and BLAST analysis 
(http://blast.ncbi.nlm.nih.gov/Blast.
cgi) based on the complete genome 
sequence showed that these newly 
CBV5 isolates have 85% identity with 
some human CBV3 strains. Because 
RNA recombination is a well-known 
phenomenon for HEVs during viral 
evolution and reemergence (5–8), 
recombination analysis between 
newly isolated CBV5 and other HEVs 
was performed by using SimPlot 
software. Similarity scanning analysis 
(online Technical Appendix Figure 1, 
wwwnc.cdc.gov/EID/pdfs/11-1524-
Techapp.pdf) by using CBV5/
CC10/10 as query sequence showed 
that the 5′ half (nt 1–4481) of the 
genome had high similarity (>93%) 
to CBV5 strain COXB5/Henan/2010, 
and the 3′ half (nt 4661–7402) showed 
high similarity (>97%) to CBV3 strain 
Beijing0811. Then, bootscanning 
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